The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical implications of polymorphisms in UDP-glucuronosyl transferase (UGT) in patients with metastatic colorectal cancer (mCRC) who were treated with oxaliplatin, irinotecan, and S-1.
Sun Young Kim
No relevant relationships to disclose
Mi Song I Jang
No relevant relationships to disclose
Hyun Mi Kim
No relevant relationships to disclose
Ji Yeon Baek
No relevant relationships to disclose
Yong Sang Hong
No relevant relationships to disclose
Kyung Hae Jung
No relevant relationships to disclose